argenx SE (ARGX)

846.27 +27.97 (+3.42%) USD  |  NASDAQ  |  Oct 15, 16:00
845.79 -0.48 (-0.06%) After-Hours: 20:00
More

argenx Research and Development Expense (Quarterly)

Research and Development Expense (Quarterly) Chart

Historical Research and Development Expense (Quarterly) Data

View and export this data back to 2014. Start Trial.
Date Value
December 31, 2015 6.965M
December 31, 2014 5.710M
September 30, 2014 4.438M
Date Value
June 30, 2014 3.737M
March 31, 2014 2.894M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Autolus Therapeutics Plc 27.95M
Cellectis SA 20.89M
Akari Therapeutics Plc 2.081M
Forte Biosciences, Inc. 22.34M
Halozyme Therapeutics, Inc. 27.66M